Lab-on-a-Chip Proteomic Assays for Psychiatric Disorders

Area of Science:

• Biomedical Engineering
• Clinical Diagnostics
• Point-of-Care Testing

Background:

• Lab-on-a-chip (LOC) assays offer potential for rapid, multiplexed analysis.
• Current diagnostic methods can be time-consuming and require specialized facilities.
• Point-of-care (POC) testing needs user-friendly, automated platforms for timely disease management.

Purpose of the Study:

• To develop and validate a fully automated multiplex immunoassay using the Fraunhofer in vitro diagnostics (ivD) platform.
• To achieve rapid assay readout (under 15 minutes) for efficient patient profiling.
• To demonstrate the platform's utility for analyzing small blood volumes for various diseases, including psychiatric disorders.

Main Methods:

• Development of a fully automated multiplex immunoassay protocol on the Fraunhofer ivD platform.
• Utilizing a single drop of blood or serum for sample analysis.
• Implementing a rapid readout system for simultaneous detection of multiple parameters.

Main Results:

• Successful demonstration of a fully automated multiplex immunoassay.
• Achieved assay readout in less than 15 minutes.
• Enabled inexpensive point-of-care profiling of patient sera.

Conclusions:

• The Fraunhofer ivD platform facilitates rapid, automated, and cost-effective multiplexed biomarker analysis.
• This technology has significant potential for point-of-care diagnostics, particularly for complex diseases like psychiatric disorders.
• The user-friendly nature of the platform supports widespread clinical adoption.